This company has been marked as potentially delisted and may not be actively trading. Cleveland BioLabs (CBLI) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrendsBuy This Stock CBLI vs. SCPS, EVLO, ARDS, STAB, CMRA, AMPE, EFTR, MTEM, ONCSQ, and PXMDShould you be buying Cleveland BioLabs stock or one of its competitors? The main competitors of Cleveland BioLabs include Scopus BioPharma (SCPS), Evelo Biosciences (EVLO), Aridis Pharmaceuticals (ARDS), Statera Biopharma (STAB), Comera Life Sciences (CMRA), Ampio Pharmaceuticals (AMPE), eFFECTOR Therapeutics (EFTR), Molecular Templates (MTEM), OncoSec Medical (ONCSQ), and PaxMedica (PXMD). These companies are all part of the "medical" sector. Cleveland BioLabs vs. Scopus BioPharma Evelo Biosciences Aridis Pharmaceuticals Statera Biopharma Comera Life Sciences Ampio Pharmaceuticals eFFECTOR Therapeutics Molecular Templates OncoSec Medical PaxMedica Scopus BioPharma (NASDAQ:SCPS) and Cleveland BioLabs (NASDAQ:CBLI) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, profitability, earnings, media sentiment, valuation, analyst recommendations, risk, institutional ownership and community ranking. Which has stronger valuation and earnings, SCPS or CBLI? Cleveland BioLabs has higher revenue and earnings than Scopus BioPharma. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioScopus BioPharmaN/AN/A-$11.61MN/AN/ACleveland BioLabs$260K0.00-$2.40MN/AN/A Which has more risk and volatility, SCPS or CBLI? Scopus BioPharma has a beta of -0.27, indicating that its share price is 127% less volatile than the S&P 500. Comparatively, Cleveland BioLabs has a beta of 0.7, indicating that its share price is 30% less volatile than the S&P 500. Does the MarketBeat Community believe in SCPS or CBLI? Cleveland BioLabs received 274 more outperform votes than Scopus BioPharma when rated by MarketBeat users. However, 100.00% of users gave Scopus BioPharma an outperform vote while only 54.87% of users gave Cleveland BioLabs an outperform vote. CompanyUnderperformOutperformScopus BioPharmaOutperform Votes2100.00% Underperform VotesNo VotesCleveland BioLabsOutperform Votes27654.87% Underperform Votes22745.13% Do insiders and institutionals have more ownership in SCPS or CBLI? 5.1% of Cleveland BioLabs shares are owned by institutional investors. 5.1% of Scopus BioPharma shares are owned by insiders. Comparatively, 1.0% of Cleveland BioLabs shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Is SCPS or CBLI more profitable? Scopus BioPharma's return on equity of 0.00% beat Cleveland BioLabs' return on equity.Company Net Margins Return on Equity Return on Assets Scopus BioPharmaN/A N/A N/A Cleveland BioLabs N/A -32.84%-31.29% Does the media prefer SCPS or CBLI? In the previous week, Scopus BioPharma's average media sentiment score of 0.00 equaled Cleveland BioLabs'average media sentiment score. Company Overall Sentiment Scopus BioPharma Neutral Cleveland BioLabs Neutral SummaryCleveland BioLabs beats Scopus BioPharma on 5 of the 9 factors compared between the two stocks. Get Cleveland BioLabs News Delivered to You Automatically Sign up to receive the latest news and ratings for CBLI and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CBLI vs. The Competition Export to ExcelMetricCleveland BioLabsPharmaceutical Preparations IndustryMedical SectorNASDAQ ExchangeMarket Cap$5,000.00$6.79B$5.50B$7.84BDividend YieldN/A3.11%5.11%4.23%P/E RatioN/A7.3322.4518.52Price / SalesN/A240.48399.68103.35Price / CashN/A65.8538.1834.62Price / BookN/A6.396.744.25Net Income-$2.40M$142.94M$3.22B$248.05M Cleveland BioLabs Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CBLICleveland BioLabsN/AN/AN/AN/A$5,000.00$260,000.000.004Short Interest ↓News CoverageGap UpSCPSScopus BioPharmaN/A$0.00flatN/AN/A$13,000.00N/A0.009EVLOEvelo BiosciencesN/A$0.00flatN/A-99.0%$9,000.00N/A0.00120ARDSAridis PharmaceuticalsN/A$0.00flatN/A-99.8%$5,000.00$3.09M0.0030High Trading VolumeSTABStatera BiopharmaN/A$0.00flatN/A-85.7%$5,000.00N/A0.0020CMRAComera Life SciencesN/A$0.00-50.0%N/AN/A$3,000.00$1.00M0.002AMPEAmpio PharmaceuticalsN/A$0.00-96.3%N/A-99.8%$1,000.00N/A0.0020High Trading VolumeEFTReFFECTOR TherapeuticsN/A$0.00flatN/A-100.0%$1,000.00$3.55M0.0010MTEMMolecular Templates1.127 of 5 starsN/AN/AN/A$1,000.00$23.48M0.00260ONCSQOncoSec MedicalN/AN/AN/AN/A$1,000.00N/A0.0040PXMDPaxMedicaN/A$0.00flatN/AN/A$1,000.00N/A0.002 Related Companies and Tools Related Companies Scopus BioPharma Alternatives Evelo Biosciences Alternatives Aridis Pharmaceuticals Alternatives Statera Biopharma Alternatives Comera Life Sciences Alternatives Ampio Pharmaceuticals Alternatives eFFECTOR Therapeutics Alternatives Molecular Templates Alternatives OncoSec Medical Alternatives PaxMedica Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CBLI) was last updated on 4/29/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored"I'm risking my reputation on this"I've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cleveland BioLabs, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cleveland BioLabs With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
